Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ANAnika Therapeutics, Inc. logo

Anika Therapeutics, Inc. (ANIK)

NASDAQ Global Select · Currency in USD
$21.42 ▲ +0.33 (+1.56%)
At close: Oct 23, 4:00 PM ET. Market closed.
$21.42 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$21.09
Open
$20.66
Day's Range
$20.60 – $21.45
52 Week Range
$9.01 – $22.88
Volume
59,202
Avg. Volume
98,679
Market Cap
$286.66M
Beta (5Y Monthly)
0.21
PE Ratio (TTM)
--
EPS (TTM)
-$0.28
Earnings Date
Nov 6, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$21.00

Profile: Anika Therapeutics, Inc.

Sector
Healthcare
Industry
Medical - Specialties
Full-time employees
235
CEO
Stephen D. Griffin
Website
anika.com

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform.

Earnings

Next report: Fri, Nov 6, 2026
EPS estimate $0.42 · Revenue est. $29.44M
DateEst.Actual
Jul 29, 2026$0.03$0.42Beat
Apr 29, 2026-$0.07$0.27Beat
Feb 26, 2026-$0.13$0.31Beat
Nov 5, 2025$0.02$0.04Beat
Jul 30, 2025-$0.13-$0.13Beat
May 9, 2025$0.09-$0.06Miss

Analyst view

Consensus price target
$21.00 ▼ -2.0%
Range $21.00 – $21.00
Rating: Buy
Buy 57% · Hold 43% · Sell 0%

Get free alerts on ANIK and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.